In this study, consistent with IBD patients, high levels of pro-inflammatory factors (IL-6, IL-1β and TNF-α) were found in mice with DSS-induced colitis, while these pro-inflammatory factors were reduced after treatment with GPH extracts, and high-dose extracts had a stronger inhibitory effect. The gene discussed is IL1B; the disease is inflammatory bowel disease.